Lataa...
Systemic Therapy for Advanced Soft Tissue Sarcomas
Soft tissue sarcomas (STS) are a rare, heterogeneous group of solid tumors in need of improved therapeutic options. First-line chemotherapy is considered the current standard of care for patients with advanced, symptomatic STS, but the median survival is only 8 to 12 months. Efforts to increase resp...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wiley Subscription Services, Inc., A Wiley Company
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3412982/ https://ncbi.nlm.nih.gov/pubmed/21837668 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.26415 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|